---
url: "https://www.lek.com/leadership/lain-anderson"
title: "Lain Anderson | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/lain-anderson#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Lain Anderson

Lain Anderson is a Managing Director and Partner in L.E.K. Consulting’s Boston office. He joined L.E.K. in 2005 and is Co-Head of the firm’s Healthcare sector, specializing in the firm’s Biopharma and Life Sciences practice. He supports clients across many life sciences industry segments and advises on a range of needs including corporate and business unit growth strategy, R&D portfolio prioritization, product launch planning and commercialization, business development strategy, due diligence, strategic budgeting, revenue forecasting, and valuation. In 2017, Lain was selected as a [Rising Star of the Consulting Profession by Consulting Magazine](https://www.lek.com/press/leks-lain-anderson-named-2017-rising-star-profession-consulting-magazine).

Lain holds a BS in management from the Carroll School of Management at Boston College. He also received his MBA with distinction from the Tuck School of Business at Dartmouth. During his time at Tuck, Lain worked in business development at Alnylam Pharmaceuticals, developing commercial assessments for the company’s portfolio.

### Education

**Undergraduate:** Bachelor of Science in Management, Carroll School of Management at Boston College

**Graduate:** Master of Business Administration, The Tuck School of Business at Dartmouth College

![Lain Anderson, L.E.K. Consulting](https://www.lek.com/sites/default/files/profile-images/lain-anderson_web.jpg)

### Lain's Expertise

#### Industries

[Private Equity Consulting](https://www.lek.com/industries/private-equity-pe)

[Biotech and Pharmaceuticals](https://www.lek.com/industries/life-sciences-pharma/biotech-pharmaceutical)

[Pharma Services](https://www.lek.com/industries/life-sciences-pharma/pharma-services)

[Commercial Due Diligence](https://www.lek.com/industries/private-equity-pe/commercial-due-diligence-cdd)

[Portfolio Company Value Enhancement](https://www.lek.com/industries/private-equity-pe/portfolio-company-value-enhancement)

[Vendor Due Diligence](https://www.lek.com/industries/private-equity-pe/vendor-due-diligence-vdd)

#### Capabilities

[Digital](https://www.lek.com/capabilities/digital)

[Marketing & Sales](https://www.lek.com/capabilities/marketing-and-sales)

[Mergers & Acquisitions](https://www.lek.com/capabilities/mergers-acquisitions)

[Organization Design and Effectiveness](https://www.lek.com/capabilities/organizational-strategy)

[Strategy](https://www.lek.com/capabilities/strategy)

Read more

### Related Insights

[News\\
\\
**Big Chinese pharma firms can withstand Trump’s policies with cost advantages: analysts**\\
\\
Tue, 05/13/2025 - 12:00](https://www.lek.com/press/big-chinese-pharma-firms-can-withstand-trumps-policies-cost-advantages-analysts)

[Article\\
\\
\\
**Life Sciences & Pharma****Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors**\\
\\
July 2, 2024](https://www.lek.com/insights/hea/global/ar/impact-us-biosecure-act-biopharmas-contract-services-and-investors)

[Special Report\\
\\
\\
**Healthcare Services****Global Health and Healthcare Strategic Outlook: A Shared Vision for 2035 (China Edition)**\\
\\
June 26, 2023](https://www.lek.com/insights/hea/cn/sr/global-health-and-healthcare-strategic-outlook-shared-vision-2035-china-edition)

[Video / Webinar\\
\\
\\
**Life Sciences & Pharma****Meet L.E.K.’s Life Sciences Biopharma Team**\\
\\
February 28, 2023](https://www.lek.com/insights/hea/global/vd/meet-leks-life-sciences-biopharma-team)

[Special Report\\
\\
\\
**Healthcare Services****Global Health and Healthcare Strategic Outlook: A Shared Vision for 2035**\\
\\
January 9, 2023](https://www.lek.com/insights/hea/global/sr/global-health-and-healthcare-strategic-outlook-2023)

[Executive Insights\\
\\
\\
**Biotech and Pharmaceuticals****The Hub-and-Spoke Model: An Emerging Biopharma Trend**\\
\\
May 6, 2022](https://www.lek.com/insights/ei/hub-and-spoke-model-emerging-biopharma-trend)

- [Load more](https://www.lek.com/leadership/lain-anderson?page=1 "Load more items")

### Meet L.E.K.’s Life Sciences Biopharma Team

![](https://fast.wistia.com/embed/medias/lv0mcxki8l/swatch)

![Video Thumbnail](https://fast.wistia.com/embed/medias/lv0mcxki8l/swatch)

![Video Thumbnail](https://embed-ssl.wistia.com/deliveries/357af291d18c17fe97a4a4c9a74598b2.webp?image_crop_resized=1920x1080)

Click for sound

2:41

![Lain Anderson](https://www.lek.com/sites/default/files/teaser-images/meet-biopharma-team_teaser.jpg)

##### Life Sciences & Pharma

#### Meet L.E.K.’s Life Sciences Biopharma Team

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×